Catriona Hay

Dr. Catriona Hay

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 1997 in Neuroscience
Verified
Journal Article
Closed access
CHCatriona Hay
Catriona Hay
MTM.A Trevethick
M.A Trevethick
AWA Wheeldon
A Wheeldon
JBJ.S Bowers
J.S Bowers
JBJ.S De Belleroche
J.S De Belleroche

1 March 1997 in NeuroReport
Verified
Journal Article
Closed access
CHCatriona Hay
Catriona Hay
JBJacqueline de Belleroche
Jacqueline de Belleroche
THE discovery of the inducible form of cyclo-oxygenase, known as cyclo-oxygenase-2 (COX-2), has provided insight into the mechanisms involved in the inflammatory response. Peripheral inflammation induced by intraplantar injection of carrageenan is associated with a marked increase in COX-2 mRNA and prostaglandins in the surrounding tissue and the accompanying oedema is sensitive to COX-2-selective drugs. In this study, we investigated whether COX-2 in spinal cord was similarly induced by carrageenan and whether the associated development of altered pain sensitivity, hyperalgesia was affected by the COX-2 selective inhibitor DuP 697. Intraplantar injection of carrageenan caused a marked hyperalgesia at 4 h which was significantly attenuated by treatment with DuP 697 (10 mg kg−1). At the same time levels of COX-2 mRNA in lumbar spinal cord were significantly increased two-fold by carrageenan treatment. However, DuP 697 potentiated COX-2 mRNA induction, which indicates the existence of a potential regulatory mechanism to overcome COX-2 inhibition.

1 February 2021 in International Dairy Journal
Verified
Journal Article
Closed access
CHCatriona Hay
Catriona Hay
AMAmanda Dupas de Matos
Amanda Dupas de Matos
Julia LowJulia Low
Julia Low
JFJing Feng
Jing Feng
DLDi Lu
Di Lu
JHJoanne Hort
Joanne Hort


1 June 2003 in Biochemical Journal
Verified
Journal Article
Closed access
PCPaul Chapple
Paul Chapple
CGCelene Grayson
Celene Grayson
AHAlison J. Hardcastle
Alison J. Hardcastle
TBTracey A. Bailey
Tracey A. Bailey
Karl MatterKarl Matter
Karl Matter
MCMichael E. Cheetham
Michael E. Cheetham
Mutations in the retinitis pigmentosa protein gene RP2 account for up to 15% of X-linked retinitis pigmentosa. RP2 is a novel protein of unknown function, which is targeted to the plasma membrane by dual N-terminal acyl-modification. Dual-acylated proteins are targeted to lipid rafts, and some are subject to polarized sorting. Therefore we investigated the organization of RP2 on the plasma membrane. Endogenous RP2 protein was predominantly localized at the plasma membrane, and exogenously expressed green-fluorescent-protein-tagged protein was also targeted to the membrane in a wide range of cultured cells. High levels of endogenous RP2 protein were present in HeLa cells and in the retinal pigment epithelium-derived cell line ARPE19. A significant proportion of RP2 in cultured neuroblastoma cells was associated with detergent-resistant membranes (DRMs), but much less than other dually acylated proteins (e.g. Lyn and Fyn). In contrast, the RP2-interacting protein Arl3 (ADP-ribosylation factor-like 3) was not found to be associated with DRMs. The association of RP2 with DRMs was cholesterol-dependent. In polarized epithelial cells in culture and in vivo, RP2 was present in both the apical and basolateral domains of the plasma membrane. These data show that RP2 is not specific to either domain, unlike some other dually acylated proteins. Interestingly, the level of RP2 protein increased in the epithelial cell line Caco-2 with differentiation and polarization. These data show that RP2 is present on the membrane of all cell types examined both in vitro and in vivo, and that RP2 associates with lipid rafts, suggesting a potential role for the protein in signal transduction.

1 December 1995 in Brain Research
Verified
Journal Article
Closed access
CHCatriona Hay
Catriona Hay
LVLisa Virgo
Lisa Virgo
GMGeorge Mentis
George Mentis
RNRoberto Navarrete
Roberto Navarrete
JBJaqueline de Belleroche
Jaqueline de Belleroche